Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
12/17/1991 | CA1293253C Antioestrogenic phenol derivatives |
12/17/1991 | CA1293248C2 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds |
12/15/1991 | WO1991019718A1 Reveromycin a, production thereof, and antitumor drug and fungicide |
12/13/1991 | CA2044333A1 Chemotherapeutic agents |
12/12/1991 | WO1991019739A1 Multivalent antigen-binding proteins |
12/12/1991 | WO1991019725A2 Heterocyclic anthracyclione and anthracycline analogs |
12/12/1991 | WO1991018604A1 Use of tetrahydroisoquinoline derivatives for preparing antitumoral drugs |
12/12/1991 | WO1991018599A2 1,4-dihydropyridines for application in combatting resistance to drugs |
12/12/1991 | WO1991018594A1 The pharmacological use of certain cystine derivatives |
12/12/1991 | WO1991004754A3 Illudin analogs as anti-tumor agents |
12/12/1991 | WO1991001958A3 11β-ARYL-GONA-4,9-DIEN-3-ONES |
12/12/1991 | CA2085120A1 Heterocyclic anthracyclinone and anthracycline analogs |
12/12/1991 | CA2064829A1 Multivalent antigen-binding proteins |
12/12/1991 | CA2044201A1 Inactive precursor forms of ribosome inactivating proteins, a process for making and a method of using |
12/12/1991 | CA2044061A1 Epipodophyllotoxin glycosides |
12/11/1991 | EP0460910A2 Tumor cell growth inhibitor |
12/11/1991 | EP0460232A1 Tumor cell growth inhibitor |
12/11/1991 | EP0460072A1 Human elastase inhibitor |
12/11/1991 | EP0235187B1 Polypeptides and antibodies characteristic of the papillomavirus, methods of diagnosis and vaccines in which they are used |
12/11/1991 | CN1015059B Isoquinoline derivatives |
12/10/1991 | US5072042 Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom |
12/10/1991 | US5072004 Using blocking, deblocking strategy |
12/10/1991 | US5071984 Dc-52 derivatives |
12/10/1991 | US5071969 Sulphated k5 antigen and sulphated k5 antigen fragments |
12/10/1991 | US5071848 Tricyclic quinoline antineoplastic agents |
12/10/1991 | US5071835 Ribonucleotide reductase inhibitors |
12/10/1991 | US5071761 Dna sequence coding for human lymphoblastoid interferons |
12/08/1991 | WO1991018884A1 Bis-naphthalimides as anticancer agents |
12/08/1991 | CA2084643A1 Bis-naphthalimides anticancer agents |
12/07/1991 | WO1991018617A1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae |
12/05/1991 | DE4017439A1 New PEG ether or ester derivs. of tumour active or diagnostic agents - with longer in vivo lifetime and high levels in tumours, for nuclear medicine, chemotherapy, fluorescent diagnosis of photo-dynamic therapy |
12/04/1991 | EP0459730A2 Anti-tumour compounds |
12/04/1991 | EP0459367A1 Method for preparing an antitumor dextran |
12/04/1991 | EP0459200A2 Chlorin derivatives |
12/04/1991 | EP0458911A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs) |
12/04/1991 | EP0458901A1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
12/04/1991 | EP0458886A1 Agents for diagnosing and treating melanomas, aromatic halogenated derivatives usable as such agents and their preparation. |
12/04/1991 | CN1056684A Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides pharmaceuticals containing these compounds and their use |
12/04/1991 | CN1014990B 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith |
12/03/1991 | US5070092 Pyrroloindole derivatives related to dc-88a compound |
12/03/1991 | CA1292749C Platinum complexes |
12/03/1991 | CA1292686C Pharmaceutical compositions of recombinant interleukin-2 and formulation process |
12/01/1991 | CA2042922A1 Anti-tumour compounds |
12/01/1991 | CA2042536A1 Method for preparing an antitumor dextran |
11/28/1991 | WO1991018016A1 Biologically active peptides containing d-2-alkyltryptophan |
11/28/1991 | WO1991018007A1 Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents |
11/28/1991 | WO1991018006A1 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |
11/28/1991 | WO1991017773A2 New protein-polycation conjugates |
11/28/1991 | WO1991017770A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
11/28/1991 | WO1991017753A1 Bistriazenes as chemotherapeutic agents |
11/28/1991 | WO1991017748A1 Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs |
11/28/1991 | WO1991005754A3 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
11/28/1991 | CA2083391A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
11/27/1991 | CN1056500A 3'-deamino-4'-deoxy-4'-amino-8-fluoroan-thracyclines and processes for their preparation |
11/27/1991 | CN1056427A Gene therapy for cell proliferative diseases |
11/27/1991 | CN1014895B Process for preparation of 4(3h)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d) pyrimidine derivatives |
11/26/1991 | WO1991018921A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2 |
11/26/1991 | US5068349 Mitomycin derivatives |
11/26/1991 | US5068222 Polypeptides for treatment of cancer |
11/26/1991 | CA2083688A1 Growth factor which inhibits the growth of cells overexpressing the human oncogene erbb-2 |
11/26/1991 | CA1292468C Nucleosides of 5-monofluoromethyluracil and 5- difluoromethyluracil |
11/23/1991 | CA2042973A1 Tgf-beta compositions |
11/22/1991 | WO1991017987A1 Phenol and pyridinol derivatives as pharmaceuticals |
11/22/1991 | CA2081982A1 Phenol and pyridinol derivatives as pharmaceuticals |
11/21/1991 | EP0457716A1 Naphthalin derivatives |
11/21/1991 | EP0457570A1 Nucleoside-phospholipid conjugate |
11/21/1991 | EP0457539A1 Dietary fiber, its process and physiologically active composition containing the same as an active ingredient |
11/21/1991 | EP0457438A2 Conjugate compounds containing aza-macrocycles, and processes for their preparation |
11/21/1991 | EP0457250A2 Novel bifunctional linking compounds, conjugates and methods for their production |
11/21/1991 | EP0457215A1 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines and processes for their preparation |
11/21/1991 | DE4115559A1 Antitumormittel mit verminderter toxizitaet auf der basis von cytostatika und xanthogenaten Anti-tumor agent with reduced toxicity on the basis of cytostatics and xanthates |
11/19/1991 | US5066828 Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
11/19/1991 | US5066645 Antitumor agents |
11/19/1991 | CA1292239C Cycloalkyl-substituted 4-aminophenyl halo derivatives and process for their preparation |
11/18/1991 | WO1991017749A1 Growth inhibitors and methods of treating cancer and cell proliferative diseases |
11/18/1991 | CA2084208A1 Growth inhibitors and methods of treating cancer and cell proliferative diseases |
11/16/1991 | WO1991017757A1 Anti-tumor agents having reduced toxicity on the basis of cytostatic agents and xanthogenates |
11/16/1991 | CA2064067A1 Anti-tumor agents having reduced toxicity on the basis of cytostatic agents and xanthogenates |
11/15/1991 | WO1991018099A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
11/15/1991 | CA2042463A1 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines and processes for their preparation |
11/14/1991 | WO1991017248A1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
11/14/1991 | WO1991017181A1 Cyclized and linear therapeutic peptides |
11/14/1991 | WO1991017151A1 New pharmacologically active catechol derivatives |
11/14/1991 | WO1991016916A1 Antineoplastic agent |
11/14/1991 | WO1991013890A3 Diastereoisomeric compounds derived from tetrahydrofolic acid, process for their preparation and use in the synthesis of diastereoisomers 6s and 6r of reduced folates |
11/14/1991 | DE4014510A1 Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie Variant CD44-oberflaechenproteine, this encoding c-dna sequences, antibodies against these proteins and their use in the diagnosis and therapy |
11/14/1991 | CA2081890A1 Cyclized and linear therapeutic peptides |
11/13/1991 | EP0456514A1 2-Fluoroneplanocin A and its production |
11/13/1991 | EP0456214A1 Fluorinated derivatives of mevinic acids |
11/13/1991 | EP0456133A1 Hydrazones |
11/13/1991 | EP0444129A4 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use |
11/13/1991 | EP0236385B1 A superoxide dismutase |
11/12/1991 | WO1991018100A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
11/12/1991 | WO1991017761A1 Targeted protection from cytotoxins |
11/12/1991 | US5064945 Chartreusin derivatives and salts thereof |
11/12/1991 | US5064849 Heterocyclic derivatives useful as radiosensitizing agents and antiviral agents |
11/12/1991 | US5064832 Biaryl compounds |
11/12/1991 | CA2082507A1 Targeted protection from cytotoxins |
11/12/1991 | CA2040530A1 Fluorinated derivatives of mevinic acids |
11/12/1991 | CA1291991C Antioestrogenic phenol derivatives |